High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production
- 991 Downloads
A bioengineered heparin, as a replacement for animal-derived heparin, is under development that relies on the fermentative production of heparosan by Escherichia coli K5 and its subsequent chemoenzymatic modification using biosynthetic enzymes. A critical enzyme in this pathway is the mammalian 6-O-sulfotransferase (6-OST-1) which specifically sulfonates the glucosamine residue in a heparin precursor. This mammalian enzyme, previously cloned and expressed in E. coli, is required in kilogram amounts if an industrial process for bioengineered heparin is to be established. In this study, high cell density cultivation techniques were exploited to obtain recombinant 6-OST-1. Physiological studies were performed in shake flasks to establish optimized growth and production conditions. Induction strategies were tested in fed-batch experiments to improve yield and productivity. High cell density cultivation in 7-l culture, together with a coupled inducer strategy using isopropyl β-d-1-thiogalactopyranoside and galactose, afforded 482 mg l−1 of enzyme with a biomass yield of 16.2 mg gcdw −1 and a productivity of 10.5 mg l−1 h−1.
KeywordsBioengineered heparin High cell density cultivations Heparosan Sulfotransferase
The authors would like to thank the USA–Italy Fulbright Commission to have selected Dr. Restaino as Fulbright Visiting Scientist and to have supported her during this work. This research was supported by grant HL096972 from the National Institutes of Health and by the Bioengineered Heparin Consortium.
- Carvalho RJ, Cabrera-Crespo J, Tanizaki MM, Gonçalves VM (2012) Development of production and purification processes of recombinant fragment of Pneumococcal surface protein A in Escherichia coli using different carbon sources and chromatography sequences. Appl Microbiol Biotechnol 94(3):683–694CrossRefGoogle Scholar
- Guerrini M, Beccati D, Shriver Z, Naggi AM, Bisio A, Capila I, Lansing J, Guglieri S, Fraser B, Al-Hakim A, Gunay S, Viswanathan K, Zhang Z, Robinson L, Venkataraman G, Buhse L, Nasr M, Woodcock J, Langer R, Linhardt RJ, Casu B, Torri G, Sasisekharan R (2008) Oversulfated chondroitin sulfate is a major contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26:669–775CrossRefGoogle Scholar